HEXB and Alzheimer disease: Another novel microglia gene-targeting model is based on the hexosaminidase subunit beta (HEXB), the lysosomal enzyme required for ganglioside GM2 degradation and a stably expressed microglial gene with no downregulation during pathology in some AD models, such as 5xFAD.